Trial Profile

Azilsartan/Amlodipine (Zacras) Combination Tablets LD & HD Specified Drug-use Survey "Long-term Use Survey"

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 06 Jun 2019

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Amlodipine/azilsartan (Primary)
Indications Hypertension
Focus Adverse reactions
Sponsors Takeda

Most Recent Events

26 Mar 2018 Planned number of patients changed from 1000 to 1090.
06 Jun 2017 Status changed from active, no longer recruiting to completed.
21 Feb 2017 Planned End Date changed from 1 Jan 2017 to 1 May 2017.

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com